ISO 9001:2015 and ISO 13485:2016
Desculpe-nos, mas este texto esta apenas disponível em English. Share this:

Desculpe-nos, mas este texto esta apenas disponível em English. Share this:

(English) Biomarker data from Astra Zeneca demonstrates that biomarkers enhance success in every aspect (safety, dosing, efficacy, patient selection) of every state of the drug development process.

(English) ImmunoSite Technologies, LLC receives the 2013 Innovative Business award

Desculpe-nos, mas este texto esta apenas disponível em English. Share this:

Press Release, February 28, 2013 ImmunoSite Technologies, LLC (IST), a provider of automation, design and customization of complex biological assays to biotechnology and pharmaceutical industries worldwide, announced its relocation to a newly expanded facility at 2831 Corporate Way in Miramar. With the expansion, the company will be retaining its current employees, making a capital investment […]

Executives, Engineers, and Scientists from ImmunoSite Technologies attended the Annual 2013 SLAS meeting in Orlando, Florida and brought back some of the latest technologies to integrate into new automated solutions for biological assay automation that will enhance their client’s productivity even more! Call IST to discuss your automation needs at (888) 770-4478 Share this:

Cell Culture Course helps Floridians enter, remain and advance in the workforce Full release click here. Fort Lauderdale, Fla. – October 18, 2011 – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has helped to develop a Cell Culture Workshop that is offered at the Employ Florida Banner Center for Life Sciences, […]


Leading provider of particle testing services now receives referrals of customers seeking particle characterization services from Beckman Coulter, Inc. Fort Lauderdale, Fla. – April 3, 2011 – ImmunoSite Technologies, LLC, a leading provider of immune monitoring services, is now receiving direct customer referrals for particle testing services from Beckman Coulter, Inc. as part of a […]
